| Disulfiram | Approved Investigational | ZNF20 | 7568 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ZNF20 mRNA | 19p13.2 | |
| Disulfiram | Approved Investigational | ZNF217 | 7764 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of ZNF217 mRNA | 20q13.2 | |
| Disulfiram | Approved Investigational | ZNF34 | 80778 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ZNF34 mRNA | 8q24.3 | |
| Disulfiram | Approved Investigational | ZNF35 | 7584 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ZNF35 mRNA | 3p21.31 | |
| Disulfiram | Approved Investigational | ZNF408 | 79797 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ZNF408 mRNA | 11p11.2 | |
| Disulfiram | Approved Investigational | ZNF622 | 90441 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ZNF622 mRNA | 5p15.1 | |
| Disulfiram | Approved Investigational | ZNF77 | 58492 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ZNF77 mRNA | 19p13.3 | |
| Disulfiram | Approved Investigational | ZNF778 | 197320 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ZNF778 mRNA | 16q24.3 | |
| Dobutamine | Approved Investigational | REN | 5972 |
upregulated | Dobutamine results in increased expression of REN mRNA | 1q32.1 | |
| Docetaxel | Approved Investigational | ABCA1 | 19 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA1 mRNA | 9q31.1 | |
| Docetaxel | Approved Investigational | ABCA10 | 10349 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA10 mRNA | 17q24.3 | |
| Docetaxel | Approved Investigational | ABCA11P | 79963 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA11P mRNA | 4p16.3 | |
| Docetaxel | Approved Investigational | ABCA3 | 21 |
downregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in decreased expression of ABCA3 mRNA | 16p13.3 | |
| Docetaxel | Approved Investigational | ABCA4 | 24 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA4 mRNA | 1p22.1 | |
| Docetaxel | Approved Investigational | ABCA5 | 23461 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA5 mRNA | 17q24.3 | |
| Docetaxel | Approved Investigational | ABCA6 | 23460 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA6 mRNA | 17q24.2-q24.3 | |
| Docetaxel | Approved Investigational | ABCA7 | 10347 |
downregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in decreased expression of ABCA7 mRNA | 19p13.3 | |
| Docetaxel | Approved Investigational | ABCA8 | 10351 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA8 mRNA | 17q24.2 | |
| Docetaxel | Approved Investigational | ABCA9 | 10350 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCA9 mRNA | 17q24.2 | |
| Docetaxel | Approved Investigational | ABCB1 | 5243 |
downregulated | docetaxel results in decreased expression of ABCB1 mRNA | 7q21.12 | |
| Docetaxel | Approved Investigational | ABCB1 | 5243 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Docetaxel | Approved Investigational | ABCB1 | 5243 |
upregulated | [docetaxel results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Docetaxel | Approved Investigational | ABCB1 | 5243 |
upregulated | docetaxel results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Docetaxel | Approved Investigational | ABCB1 | 5243 |
downregulated | [docetaxel results in increased expression of TP53 mRNA] which results in decreased expression of ABCB1 mRNA | 7q21.12 | |
| Docetaxel | Approved Investigational | ABCB4 | 5244 |
upregulated | [docetaxel results in decreased susceptibility to docetaxel] which results in increased expression of ABCB4 mRNA | 7q21.12 | |